1. Home
  2. FRSH vs IRON Comparison

FRSH vs IRON Comparison

Compare FRSH & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

N/A

Current Price

$11.87

Market Cap

3.4B

Sector

Technology

ML Signal

N/A

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$74.14

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRSH
IRON
Founded
2010
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FRSH
IRON
Price
$11.87
$74.14
Analyst Decision
Buy
Strong Buy
Analyst Count
15
11
Target Price
$14.86
$103.18
AVG Volume (30 Days)
5.0M
398.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
296.88
N/A
EPS
N/A
N/A
Revenue
$838,809,000.00
N/A
Revenue This Year
$16.30
N/A
Revenue Next Year
$14.09
$283.52
P/E Ratio
N/A
N/A
Revenue Growth
16.43
N/A
52 Week Low
$6.79
$40.00
52 Week High
$13.99
$99.50

Technical Indicators

Market Signals
Indicator
FRSH
IRON
Relative Strength Index (RSI) 42.48 35.49
Support Level $11.62 $70.73
Resistance Level $12.28 $82.89
Average True Range (ATR) 0.41 2.78
MACD -0.26 -0.83
Stochastic Oscillator 6.61 8.31

Price Performance

Historical Comparison
FRSH
IRON

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions. It derives maximum revenue from North America.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: